DVA
DaVita HealthCare Partners Inc
NYSE: DVA · HEALTHCARE · MEDICAL CARE FACILITIES
$198.93
-0.01% today
Updated 2026-06-05
Market cap
$13.39B
P/E ratio
20.12
P/S ratio
0.97x
EPS (TTM)
$10.37
Dividend yield
—
52W range
$101 – $212
Volume
0.8M
WallStSmart proprietary scores
70
out of 100
Grade: B
Buy
Investment rating
7.3
Growth
B+5.5
Quality
C+6.5
Profitability
B5.3
Valuation
C+3/9
Piotroski F-Score
Weak
1.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$193.71
-2.62%
12-Month target
$153.33
-22.92%
Intrinsic (DCF)
$123.34
Margin of safety
-16.97%
0 Strong Buy2 Buy4 Hold0 Sell2 Strong Sell
Price chart
Stock snapshot
Strengths
+ ROE 81.00% — strong efficiency
+ Free cash flow $218.81M — positive
+ Debt/equity -17.50x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 1.22 — distress zone
- 16.97% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $11.61B | $12.14B | $12.82B | $13.64B | $13.84B |
| Net income | $560.40M | $691.53M | $936.34M | $746.80M | $197.53M |
| EPS | — | — | — | — | $10.37 |
| Free cash flow | $961.14M | $1.49B | $1.47B | $1.31B | $218.81M |
| Profit margin | 4.83% | 5.70% | 7.31% | 5.47% | 5.65% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-26 | YALE, PHYLLIS R | Sale | 5,038 | — |
| 2026-05-15 | YALE, PHYLLIS R | Buy | 250 | — |
| 2026-05-15 | SCHOPPERT, WENDY LEE | Buy | 250 | — |
Peer comparison
Smart narrative
DaVita HealthCare Partners Inc trades at $198.93. representing a P/E of 20.12x trailing earnings. Our Smart Value Score of 70/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 1.22, it sits in the distress. TTM revenue stands at $13.84B. with profit margins at 5.65%. Our DCF model estimates intrinsic value at $123.34.
Frequently asked questions
What is DaVita HealthCare Partners Inc's stock price?
DaVita HealthCare Partners Inc (DVA) trades at $198.93, on a P/E of 20.1x and a P/S of 1.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is DaVita HealthCare Partners Inc overvalued?
DaVita HealthCare Partners Inc carries a Smart Value Score of 70/100 (Grade B), which we rate Buy. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $123.34 against the $198.93 price, so on cash flow terms the market is paying a premium for DaVita HealthCare Partners Inc's growth. The Buy rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of DaVita HealthCare Partners Inc (DVA)?
The 12-month analyst consensus target is $193.71, about 2.6% below the current $198.93. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of DaVita HealthCare Partners Inc (DVA)?
Our DCF model estimates intrinsic value at $123.34, a -17.0% margin of safety versus today's $198.93. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is DaVita HealthCare Partners Inc's revenue?
DaVita HealthCare Partners Inc's trailing twelve-month revenue is $13.84B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
DaVita HealthCare Partners Inc's Altman Z-Score is 1.22, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.97x
ROE81.00%
Beta0.91
50D MA$175.44
200D MA$140.89
Shares out0.06B
Float0.03B
Short ratio—
Avg volume0.8M
Performance
1 week+0.00%
1 month-3.79%
3 months+27.49%
YTD+69.14%
1 year—
3 years—
5 years—